Publication | Closed Access

A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial)

Surgical OncologyNanotherapeuticsUrologyGenitourinary CancerTherapeutic NanomaterialsMedicineProspective Phase 2AIrene TrialOncologyRadiation OncologyPilot Study